Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Journal of Medicinal Chemistry|June 30, 2022
Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PETDaniel Gündel, Winnie Deuther-Conrad, Lea Ueberham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2Gil Leurquin-Sterk, Sofie Celen, Koen Van Laere, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjectsKoen Van Laere, Michel Koole, Sandra M Sanabria Bohorquez, et al.
Molecular Imaging|April 1, 2016
Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807Lieven Declercq, Sofie Celen, Joan Lecina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2017
Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau ImagingLieven Declercq, Frederik Rombouts, Michel Koole, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody FragmentsAnneleen Blykers, Steve Schoonooghe, Catarina Xavier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
A PET brain reporter gene system based on type 2 cannabinoid receptorsCaroline Vandeputte, Nele Evens, Jaan Toelen, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Single-word comprehension deficits in the nonfluent variant of primary progressive aphasiaJolien Schaeverbeke, Silvy Gabel, Karen Meersmans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446Michel Koole, Mark E Schmidt, Anja Hijzen, et al.
Pageof 23